about
Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience.Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.Myeloid sarcoma in children - diagnostic and therapeutic difficulties.Vascular endothelial growth factor (VEGF)-C - a potent risk factor in children diagnosed with stadium 4 neuroblastoma.Unusual case of desmotropy. Combined spectroscopy (¹H-¹⁴N NQDR) and quantum chemistry (periodic hybrid DFT/QTAIM and Hirshfeld surface-based) study of solid dacarbazine (anti-neoplastic).Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene.Atypical thymic carcinoid manifesting with nephrotic-range proteinuria in a 7-year-old boy.Massively parallel targeted resequencing reveals novel genetic variants associated with aspergillosis in paediatric patients with haematological malignancies.Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate.Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients--implications for RQ-PCR-based assessment of minimal residual diseaseThe immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
P50
Q33588450-468B51FB-CA68-4D9F-BC88-BE56D865B52FQ37101299-884CBA7E-D30E-48F6-8B56-7AE67BD22F0CQ37727506-F4076FE2-4E5F-4FA9-B036-F7B95FE100C1Q39151887-7A2A8279-7827-4048-9351-49206C7DC10AQ40010525-5164F5D3-A17C-4070-9D12-E0643C02B2C1Q40983133-0A502CCC-4C19-4854-ADC1-616C5F2B22C7Q45323271-9866E7E2-23E3-4C89-B9E5-90D759AAB79AQ48183028-3B71B633-5532-4041-8F01-B2CF66E402A1Q49830279-8A8CB564-AE2D-4F9F-AD79-4A2E8BCEE61DQ50079472-488694FA-E9EF-4CCF-9786-5E1352A8909AQ50102649-C947732C-4184-443A-9D2E-6C99E4DFA063Q51375505-C800710B-FCFA-489F-91BF-28402A7D3E3FQ53765766-CE3E670E-12CC-4E6B-AA0F-DF54DE33A805Q54294058-BFF71C9C-A8CA-4032-804D-6CB47128CCDEQ82544479-AF4196AB-E49B-4B06-8355-CD9C649D8F8DQ87915511-273F0588-1DDC-4545-BC4E-B7DCE75DE5E7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katarzyna Derwich
@ast
Katarzyna Derwich
@en
Katarzyna Derwich
@es
Katarzyna Derwich
@nl
type
label
Katarzyna Derwich
@ast
Katarzyna Derwich
@en
Katarzyna Derwich
@es
Katarzyna Derwich
@nl
prefLabel
Katarzyna Derwich
@ast
Katarzyna Derwich
@en
Katarzyna Derwich
@es
Katarzyna Derwich
@nl
P214
P106
P1153
6507108574
P214
P31
P496
0000-0001-7239-4035
P7859
viaf-250336732